|
KCTD20 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62792999999217E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.229580E-04 |
| Normal-vs-Stage2 |
1.960460E-03 |
| Normal-vs-Stage3 |
5.68730000000128E-05 |
| Normal-vs-Stage4 |
2.177800E-04 |
| Stage1-vs-Stage2 |
8.298000E-01 |
| Stage1-vs-Stage3 |
2.767200E-01 |
| Stage1-vs-Stage4 |
4.135400E-01 |
| Stage2-vs-Stage3 |
5.900200E-01 |
| Stage2-vs-Stage4 |
6.218200E-01 |
| Stage3-vs-Stage4 |
9.793200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.77200000000188E-05 |
| Normal-vs-AfricanAmerican |
4.377900E-02 |
| Normal-vs-Asian |
1.083260E-03 |
| Caucasian-vs-AfricanAmerican |
5.426400E-01 |
| Caucasian-vs-Asian |
7.961400E-01 |
| AfricanAmerican-vs-Asian |
4.725200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.225200E-04 |
| Normal-vs-Female |
1.74184999999216E-05 |
| Male-vs-Female |
9.381400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.683910E-03 |
| Normal-vs-Age(41-60Yrs) |
2.29119999994865E-06 |
| Normal-vs-Age(61-80Yrs) |
4.06619999999691E-05 |
| Normal-vs-Age(81-100Yrs) |
2.154200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.162600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.547200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.732600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.531400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.821200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.215200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.339000E-01 |
| Classical-VS-Follicular |
6.464000E-03 |
| Classical-VS-Other |
3.726000E-02 |
| Classical-VS-Normal |
6.375700E-04 |
| Tall-VS-Follicular |
4.716600E-01 |
| Tall-VS-Other |
1.127640E-01 |
| Tall-VS-Normal |
3.118700E-03 |
| Follicular-VS-Other |
2.746400E-01 |
| Follicular-VS-Normal |
4.01620000001213E-06 |
| Other-VS-Normal |
2.124000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.59310000045355E-07 |
| Normal-vs-N1 |
5.63780000000236E-05 |
| N0-vs-N1 |
6.108000E-01 |
|
|
